ALA-3000

· Alar Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALA-3000, covering 2025-12-31 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Ascending Dose Phase 1 Study of ALA-3000 [Phase 1]